Loading...
Loading...
African Journal of Biology and Medical Research
Vol. 7Issue 42024pp. 23–30Published 18 October 2024
DOI 10.52589/AJBMR-IFZAK9VQResearch Article
Share Link
Cite this
Citation unavailable for this article.
Abstract:
We conducted a cross-sectional survey on the impact of ivermectin after repeated treatment in five communities in Imo State, Nigeria. Rapid epidemiological mapping of onchocerciasis (REMO) carried out in 450 subjects in 1994 prior to the launching of mass drug administration were compared with re-examinations of 540 subjects in 2023. We found palpable nodule reduction from 47.2% to 12.2% and popular dermatitis decrease from 42.9% to 5.9%. Reductions in other clinical features were observed. Overall, a significantly higher proportions of males were infected than females (P<0.05). The implications of these results were discussed in line with the reported benefits of ivermectin therapy.
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights